Coronary Artery Disease

Clinical Trial Finder

Many patients with coronary artery disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Medtronic Resolute Onyx Core (2.25 mm - 4.0 mm) Clinical Study

Condition:   Coronary Artery Disease
Intervention:   Device: Resolute Onyx Stent - 2.25 mm - 4.0 mm
Sponsor:   Medtronic Vascular
Not yet recruiting - verified April 2015

Changes in the Risk Factors of Coronary Heart Disease Observed After Scaling and Root Planing

Conditions:   Coronary Heart Disease;   Periodontitis
Interventions:   Device: piezoelectric ultrasonic scaler (frequency of 28-36 KHz);   Device: Gracey curettes
Sponsor:   Government College of Dentistry, Indore
Completed - verified April 2015

A Study to Obtain Additional Information on the Use of CorMatrix® CanGaroo ECM® Envelope

Condition:   Coronary Disease
Intervention:   Device: CorMatrix CanGaroo ECM Envelope
Sponsor:   CorMatrix
Not yet recruiting - verified April 2015

Therapeutic Use of Ultrasound in Acute Coronary Artery Disease

Condition:   Acute Myocardial Infarction
Interventions:   Procedure: Therapeutic ultrasound with 20 usec;   Procedure: Repeated diagnostic high mechanical index
Sponsors:   University of Sao Paulo General Hospital;   University of Nebraska
Recruiting - verified April 2015

Medtronic Resolute Onyx 2.0 mm Clinical Study

Condition:   Coronary Artery Disease
Intervention:   Device: Resolute Onyx Stent - 2.0 mm
Sponsor:   Medtronic Vascular
Not yet recruiting - verified April 2015

The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in CAD Patients With Diabetes Mellitus

Condition:   Coronary Artery Disease
Intervention:   Drug: rosuvastatin
Sponsor:   Sir Run Run Shaw Hospital
Not yet recruiting - verified April 2015

Identification of the Blood Microbiota in Patient Suffering From Myocardial Infraction

Conditions:   Coronary Disease;   Myocardial Infarction
Intervention:  
Sponsor:   University Hospital, Toulouse
Recruiting - verified April 2015

Short-Term Application of Tocilizumab Following Myocardial Infarction

Condition:   Myocardial Infarction
Interventions:   Drug: Tocilizumab;   Drug: Placebo
Sponsor:   Keesler Air Force Base Medical Center
Recruiting - verified April 2015

Researches of Retinal Artery Lesions and Acute Coronary Syndrome

Condition:   Acute Coronary Syndrome
Intervention:  
Sponsor:   Capital Medical University
Active, not recruiting - verified April 2015

Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention

Condition:   Acute Coronary Syndromes
Interventions:   Drug: Apixaban;   Drug: vitamin K antagonist;   Drug: Acetylsalicylic acid;   Other: Acetylsalicylic acid placebo
Sponsors:   Bristol-Myers Squibb;   Pfizer;   Duke Clinical Research Institute
Not yet recruiting - verified April 2015

Open-Labeled PK-PD Studies of Metoprolol ER

Condition:   Blood Pressure
Interventions:   Drug: Toprol XL;   Device: SmartPill Capsule;   Procedure: Exercise Treadmill;   Procedure: 24 hour holter monitor;   Other: 24-hour pharmacokinetic parameters;   Drug: Wockhardt metoprolol;   Drug: Activas metoprolol
Sponsors:   University of Florida;   Food and Drug Administration (FDA)
Not yet recruiting - verified April 2015

For Her Heart's Sake STEP Project: A Clinical Trial

Condition:   Cardiovascular Diseases
Intervention:   Behavioral: The STEP Program
Sponsors:   University of Manitoba;   Victoria General Hospital Foundation;   Reh-Fit Fitness Centre;   Wellness Institute-Seven Oaks General Hospital
Not yet recruiting - verified March 2015

Exercise Training Following Cardiac Resynchronization Therapy in Patients With Chronic Heart Failure

Conditions:   Cardiac Resynchronization Therapy;   Chronic Heart Failure
Interventions:   Behavioral: Exercise training program;   Device: Cardiac resynchronization therapy (CRT)
Sponsor:   University of Lisbon
Recruiting - verified April 2015

Metabolic, Vascular and Cognitive Effects of Treatment With Anthocyanins

Conditions:   Coronary Disease;   Inflammation;   Cognitive Impairment
Intervention:   Dietary Supplement: Anthocyanin
Sponsor:   Helse Stavanger HF
Not yet recruiting - verified April 2015

Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With NSTE-ACS

Condition:   Non ST Segment Elevation Acute Coronary Syndrome
Interventions:   Drug: low-dose ticagrelor;   Drug: conventional-dose ticagrelor;   Drug: Clopidogrel
Sponsor:   First Affiliated Hospital of Harbin Medical University
Recruiting - verified December 2014

GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease

Condition:   Ischemic Heart Disease
Interventions:   Drug: GS-6615;   Drug: Placebo
Sponsor:   Gilead Sciences
Not yet recruiting - verified April 2015

Brilinta Taiwan Post Approval Safety Study

Condition:   Non ST-elevation Myocardial Infarction
Intervention:   Drug: Ticagrelor 180mg loading dose taken orally, followed by 90mg twice daily (bd)
Sponsor:   AstraZeneca
Not yet recruiting - verified April 2015

Immediate Versus Delayed Invasive Intervention for Non-STEMI Patients

Condition:   Myocardial Infarction
Interventions:   Procedure: Immediate invasive intervention;   Procedure: Delayed invasive intervention;   Device: Coronary artery stenting
Sponsor:   Clinical Centre of Serbia
Active, not recruiting - verified April 2015

CardiOvascular Risk and idEntificAtion of Potensial High-risk Population in Acute Myocardial Infarction

Conditions:   Long-term Major Cardiovascular Events;   Myocardial Infarction;   Percutaneous Coronary Intervention
Interventions:   Device: Percutaneous coronary intervention;   Device: Percutaneous coronary intervention
Sponsors:   Kiyuk Chang;   The Catholic University of Korea;   Chonnam National University
Completed - verified April 2015

Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry

Condition:   Non-valvular Atrial Fibrillation
Intervention:  
Sponsors:   Mount Sinai School of Medicine;   Bristol-Myers Squibb
Recruiting - verified April 2015

Physical and Functional Recovery From Cardiac Surgery in Hospitalized Patients: A Feasibility Pilot Study

Conditions:   Coronary Artery Disease;   Mitral Valve Insufficiency;   Aortic Valve Stenosis;   Aortic Valve Regurgitation;   Mitral Valve Stenosis;   Coronary Artery Bypass Graft Triple Vessel
Intervention:   Procedure: Ambulation orderly
Sponsors:   Baystate Medical Center;   Springfield College
Recruiting - verified April 2015

Dose-escalation, Repeated and Single Oral Dosing Study

Condition:   Acute Coronary Syndrome
Interventions:   Drug: APD791;   Drug: Clopidogrel;   Drug: Aspirin;   Drug: Placebo for APD791
Sponsors:   IlDong Pharmaceutical Co Ltd;   Asan Medical Center
Enrolling by invitation - verified April 2015

The Role of Levothyroxine on Goiter With Atypia of Undetermined Significance

Condition:   Goiter
Intervention:   Drug: Levothyroxine
Sponsor:   Sheng-Chiang Su
Not yet recruiting - verified April 2015

Jakarta Acute Coronary Syndrome Registry

Condition:   Acute Coronary Syndrome
Intervention:   Other: JAC Registry
Sponsor:   National Cardiovascular Center Harapan Kita Hospital Indonesia
Recruiting - verified April 2015

Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension

Condition:   Acute Coronary Syndromes
Intervention:  
Sponsor:   AstraZeneca
Recruiting - verified April 2015

RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet Therapy

Condition:   Acute Coronary Syndrome
Intervention:  
Sponsor:   AstraZeneca
Not yet recruiting - verified April 2015

Removal of Cytokines During Extracorporeal Circulation in Cardiac Surgery

Conditions:   Coronary Artery Disease;   Heart Valve Diseases
Intervention:   Device: CytoSorb device
Sponsor:   Universitätsklinikum Hamburg-Eppendorf
Recruiting - verified April 2015

Cadmium-zinc-telluride (CZT) Imaging of Myocardial Blood Flow (MBF) (SPECT MBF)

Condition:   Coronary Heart Disease
Intervention:   Other: single photon emission computed tomography
Sponsors:   Ottawa Heart Institute Research Corporation;   GE Healthcare
Recruiting - verified April 2015

Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab

Condition:   Hypercholesterolemia
Intervention:   Biological: Evolocumab
Sponsor:   Amgen
Enrolling by invitation - verified April 2015

Off Pump Versus On Pump Coronary Artery Bypass Grafting in Frailty Patients (FRAGILE)

Conditions:   Coronary Artery Disease;   Complications Due to Coronary Artery Bypass Graft;   Fragility
Interventions:   Procedure: OPCAB;   Procedure: CABG
Sponsors:   University of Sao Paulo General Hospital;   InCor Heart Institute of São Paulo;   Cardiac Emergency Hospital of Pernambuco;   Alberto Urquiza Wanderley Hospital of João Pessoa;   Pitangueiras Hospital of Jundiaí;   State University of Campinas;   Cardiology Institute of the Distrito Federal;   National Cardiology Institute;   Federal University of São Paulo;   Pontifical University Catholic of Parana;   Clinical Hospital Samuel Libânio of Pouso Alegre;   Beneficência Portuguesa of São Paulo;   Pontifical University Catholic of Campinas;   InCor Heart Institute of Natal
Not yet recruiting - verified August 2014

Coronary CT Angiography Using a Novel 3rd Generation Dual-Source CT System

Condition:   Coronary Artery Disease
Interventions:   Procedure: Coronary CT angiography on SOMATOM Force;   Procedure: Previous coronary CT angiography on 2nd generation CT scanner
Sponsor:   U. Josepf Schoepf, MD
Recruiting - verified April 2015

Intravascular Ultrasound Guided Drug Eluting Stent Implantation in "All-comers" Coronary Lesions

Condition:   Coronary Artery Disease
Interventions:   Procedure: Angiography;   Procedure: IVUS;   Procedure: DES implantation
Sponsor:   The First Hospital of Nanjing Medical University
Recruiting - verified April 2015

Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Acute Myocardial Infarction

Conditions:   ST-segment Elevation Myocardial Infarction;   Non-ST-segment Elevation Myocardial Infarction;   VA Drug Interactions [VA Drug Interaction]
Interventions:   Drug: Morphine;   Drug: Placebo;   Drug: Ticagrelor
Sponsor:   Collegium Medicum w Bydgoszczy
Recruiting - verified April 2015

Using Ripple Mapping to Guide Substrate Ablation of Scar Related Ventricular Tachycardia.

Conditions:   Monomorphic Ventricular Tachycardia;   Myocardial Infarction;   Dilated Cardiomyopathy
Interventions:   Device: Ripple Mapping guided VT ablation;   Device: Conventional VT ablation
Sponsor:   Imperial College London
Recruiting - verified July 2014

Cardiovascular Patient Outcomes and Research Team Primary PCI Registry

Condition:   ST Elevation Myocardial Infarction
Intervention:  
Sponsor:   Johns Hopkins University
Recruiting - verified April 2015

All-On-4® Treatment Concept

Condition:   Edentulous
Intervention:   Device: Nobel Active, Nobel Procera IBO
Sponsor:   Nobel Biocare
Recruiting - verified July 2014

HealthMap: an Interactive Health Plan Randomised Trial to Prevent Cardiovascular Disease in People With HIV

Conditions:   HIV;   Cardiovascular Disease
Intervention:   Other: Integrated self management support
Sponsors:   Karen Klassen;   Alfred Health;   Monash University;   Australasian Society for HIV Medicine;   National Association for People with HIV Australia;   National Health and Medical Research Council, Australia;   Victorian AIDS Council;   Department of Health, Victoria;   Flinders University;   Living Positive Victoria;   New South Wales Ministry of Health;   University of Melbourne;   Deakin University
Recruiting - verified April 2015

Colchicine in Vascular Inflammation Assessed With PET Imaging

Condition:   Atherosclerotic Vascular Disease
Intervention:   Drug: Colchicine
Sponsor:   Montreal Heart Institute
Active, not recruiting - verified April 2015

Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic Therapy

Condition:   Diabetes Mellitus, Type 2
Intervention:  
Sponsor:   Boehringer Ingelheim
Completed - verified April 2015

Alpha-linolenic Acid and Blood Pressure

Conditions:   Hypertension;   Lipid Metabolism Disorders
Interventions:   Dietary Supplement: Flaxseed oil;   Dietary Supplement: high oleic sunflower oil (HOSF)
Sponsors:   Maastricht University Medical Center;   Unilever R&D
Recruiting - verified April 2015

Assessing the Effects of Omega-3 Supplementation on Serum HSP27, HSP70, YKL40, BMP-4 Levels in Male Patient With CAD

Condition:   Cardiovascular Disease
Interventions:   Dietary Supplement: Omega-3;   Dietary Supplement: Placebo
Sponsor:   Tehran University of Medical Sciences
Completed - verified April 2015

BioMime Vs. Xience Randomised Control Clinical Study

Condition:   Coronary Artery Disease
Interventions:   Device: Sirolimus Eluting Coronary Stent;   Device: Everolimus-eluting Coronary stent
Sponsor:   Meril Life Sciences Pvt. Ltd.
Recruiting - verified April 2015

Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site

Conditions:   Coronary Artery Disease;   Heart Attack;   Angina
Intervention:  
Sponsor:   Johns Hopkins University
Recruiting - verified April 2015

Observational Prospective Study OPTIMA II - Follow-up

Condition:   Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
Intervention:  
Sponsor:   AstraZeneca
Recruiting - verified April 2015

A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.

Condition:   Acute Myocardial Infarction
Interventions:   Biological: CSL112;   Biological: Placebo
Sponsor:   CSL Behring
Recruiting - verified April 2015

Triple vs. Dual Therapy

Conditions:   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Ticagrelor + Apixaban + ASA;   Drug: Ticagrelor + Apixaban
Sponsor:   Medical University of Vienna
Completed - verified April 2015

Compare Ticagrelor vs Clopidogrel on the Reduction of Arterial Stiffness and Wave Reflectionsin Patients With Coronary Artery Disease . The NOVELTY Study

Condition:   Coronary Artery Disease
Intervention:   Drug: Ticagrelor
Sponsors:   Hellenic Cardiovascular Research Society;   AstraZeneca
Recruiting - verified April 2015

The Effects of Obstructive Sleep Apnea and Its Intervention on Coronary Heart Disease

Conditions:   Hypertension;   Metabolic Disorder
Intervention:   Device: continuous positive airway pressure
Sponsor:   Chinese Pulmonary Vascular Disease Research Group
Completed - verified April 2015

Angioshield First-In-Human Study to Demonstrate the Preliminary Safety and Efficacy

Condition:   Coronary Artery Disease
Intervention:   Device: Angioshield
Sponsor:   Neograft Technologies, Incorporated
Active, not recruiting - verified April 2015

Supplementation With Polyphenol-Rich Foods and Atrial Fibrillation After a Cardiac Surgery

Condition:   Coronary Heart Disease
Interventions:   Dietary Supplement: Placebo;   Dietary Supplement: High-anthocyanin rich corn flour
Sponsor:   Neuromed IRCCS
Recruiting - verified April 2015

Ranolazine and Microvascular Angina by PET in the Emergency Department

Condition:   Microvascular Angina
Interventions:   Drug: Ranolazine;   Drug: Placebo
Sponsors:   Yale University;   Gilead Sciences
Recruiting - verified April 2015

A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes

Conditions:   Diabetic Nephropathies;   Coronary Artery Disease
Interventions:   Drug: Allopurinol;   Drug: Placebo
Sponsors:   Alessandro Doria;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Juvenile Diabetes Research Foundation;   Joslin Diabetes Center;   University of Minnesota - Clinical and Translational Science Institute;   University of Colorado, Denver;   University of Michigan;   University of Toronto;   Feinberg School of Medicine, Northwestern University;   Albert Einstein College of Medicine of Yeshiva University;   Steno Diabetes Center;   Washington University School of Medicine;   University of Washington;   Emory University;   University of Calgary;   University of Alberta
Recruiting - verified April 2015

Verification of the Safety of Early Discharge in Patients After Acute ST-segment Myocardial Infarction

Conditions:   Coronary Artery Disease;   Acute Myocardial Infarction With ST-segment Elevation;   Primary Percutaneous Coronary Intervention;   Early Discharge
Interventions:   Other: Early discharge;   Other: Standard discharge
Sponsor:   Kamil Novobílský
Recruiting - verified April 2015

Post Acute Coronary Event Smoking Study

Conditions:   Smoking Cessation;   Acute Coronary Syndrome
Interventions:   Behavioral: Behavioral Activation (BA);   Behavioral: Standard Smoking Cessation Counseling;   Drug: Nicotine patch;   Other: Printed Self-help materials for Smoking Cessation
Sponsor:   The Miriam Hospital
Active, not recruiting - verified April 2015

Xenon as an Adjuvant to Propofol Anaesthesia in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery.

Conditions:   Coronary Artery Disease;   Anesthesia
Interventions:   Drug: Xenon and propofol;   Drug: propofol
Sponsor:   Universitaire Ziekenhuizen Leuven
Completed - verified April 2015

PWV for Cardiovascular Complication After Cardiac Surgery

Condition:   C.Surgical Procedure; Cardiac
Intervention:  
Sponsors:   Seoul National University Hospital;   SMG-SNU Boramae Medical Center
Completed - verified April 2015

Non-isotope Based Imaging Modalities vs Technetium-99m Single-Photon Emission Computed Tomography(99mTcSPECT)

Condition:   Myocardial Ischemia
Intervention:  
Sponsors:   Montreal Heart Institute;   Canadian Institutes of Health Research  (CIHR)
Recruiting - verified April 2015

Relationship Between CETP Deficiency and Atherosclerosis in Patients With Hyperalphalipoproteinemia

Conditions:   Low CETP Activity;   CETP Deficiency;   Hyperalphalipoproteinemia;   Hyper-LDL-cholesterolemia;   High Level of Remnant Cholesterol
Intervention:  
Sponsors:   Osaka University;   Merck Sharp & Dohme Corp.
Recruiting - verified August 2013

Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes

Condition:   Vascular Disease
Intervention:  
Sponsor:   Montreal Heart Institute
Recruiting - verified April 2015

Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD) Including GSPECT (Gated Single Photon Emission Computed Tomography)

Condition:   Coronary Artery Disease
Intervention:   Drug: Gadobutrol (Gadovist, BAY86-4875)
Sponsor:   Bayer
Recruiting - verified April 2015

Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)

Condition:   Coronary Artery Disease
Intervention:   Drug: Gadobutrol (Gadovist, BAY86-4875)
Sponsor:   Bayer
Recruiting - verified April 2015

Walnut Consumption, Endothelial Function, and Biomarkers

Conditions:   Coronary Heart Disease;   Type 2 Diabetes
Intervention:   Other: Once ounce per day of walnuts
Sponsor:   Brigham and Women's Hospital
Active, not recruiting - verified April 2015

A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure

Conditions:   Heart Failure;   Coronary Artery Disease
Interventions:   Drug: Rivaroxaban;   Drug: Placebo;   Other: Standard of care for heart failure and coronary artery disease
Sponsors:   Janssen Research & Development, LLC;   Bayer
Recruiting - verified April 2015

Impact of Perivascular Tissue on Endothelial Function in Coronary Artery Bypass Grafting

Condition:   Myocardial Ischemia
Interventions:   Procedure: no-touch;   Procedure: conventional
Sponsors:   Norwegian University of Science and Technology;   St. Olavs Hospital
Completed - verified April 2015

Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent

Conditions:   Coronary Artery Disease;   Ischemic Heart Disease
Intervention:   Device: Drug-eluting stent
Sponsor:   Odense University Hospital
Active, not recruiting - verified April 2015

Incremental Value of Point of Care H-FABP Testing in Primary Care Patients Suspected of Acute Coronary Syndrome

Conditions:   Acute Coronary Syndrome;   Angina Pectoris, Unstable;   Angina Pectoris, Stable;   Thoracic Diseases
Intervention:   Device: heart type fatty acid binding protein testing
Sponsors:   Maastricht University Medical Center;   FABPulous B.V.
Recruiting - verified April 2015

A Prospective Multicenter Post Approval Study to Evaluate the Long-term Safety and Efficacy of the Resolute Integrity in the Japanese All-comers Patients With Coronary Artery Disease (PROPEL)

Conditions:   Coronary Artery Disease;   Drug-eluting Stent
Intervention:  
Sponsors:   Associations for Establishment of Evidence in Interventions;   Medtronic Vascular
Active, not recruiting - verified April 2015

Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors

Conditions:   Vascular Disease;   Coronary Artery Disease Risk Factors Multiple
Intervention:   Drug: PZ-128
Sponsors:   Tufts Medical Center;   National Heart, Lung, and Blood Institute (NHLBI);   Sinai Hospital of Baltimore
Completed - verified April 2015

Coronary Computed Tomographic Angiography for Selective Cardiac Catheterization

Condition:   Coronary Artery Disease
Interventions:   Procedure: Cardiac CT;   Procedure: Invasive Coronary Angiography
Sponsors:   MDDX LLC;   GE Healthcare
Recruiting - verified April 2015

Relation of Consummatory and Anticipatory Food Reward to Obesity

Conditions:   Weight Gain;   Food Habits
Intervention:  
Sponsors:   Oregon Research Institute;   National Institutes of Health (NIH)
Active, not recruiting - verified April 2015

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease

Condition:   Prevention & Control
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin;   Drug: Aspirin placebo;   Drug: Rivaroxaban placebo;   Drug: Pantoprazole
Sponsors:   Bayer;   Hamilton Health Sciences Corporation, Population Health Research Institute
Recruiting - verified April 2015

Safety and Feasibility of Using a Single Transradial Guiding Catheter for Primary PCI

Condition:   Myocardial Infarction
Interventions:   Procedure: guiding catheter;   Procedure: diagnostic catheter
Sponsor:   Beijing Luhe Hospital
Active, not recruiting - verified April 2015

Homebased Training With Telemonitoring Guidance in Low to Moderate Risk Patients Entering Cardiac Rehabilitation

Conditions:   Acute Coronary Syndrome;   Myocardial Infarction
Interventions:   Behavioral: Home-based training;   Behavioral: Centre-based training
Sponsor:   Maxima Medical Center
Active, not recruiting - verified April 2015

Intracoronary Autologous Mesenchymal Stem Cells Implantation in Patients With Ischemic Dilated Cardiomyopathy

Condition:   Ischemic Dilated Cardiomyopathy
Intervention:   Other: BM-MSCs
Sponsors:   National University of Malaysia;   Cytopeutics Sdn Bhd
Active, not recruiting - verified April 2015

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab SAR236553 (REGN727)

Condition:   Acute Coronary Syndrome
Interventions:   Drug: alirocumab SAR236553 (REGN727);   Other: placebo
Sponsors:   Sanofi;   Regeneron Pharmaceuticals
Recruiting - verified April 2015

Exercise and Low-Dose Rapamycin in Older Adults With CAD:Cardiac Rehabilitation And Rapamycin in Elderly (CARE) Trial

Conditions:   Aging;   CAD
Intervention:   Drug: Rapamycin
Sponsor:   Mayo Clinic
Recruiting - verified April 2015

Long-term Clinical Outcome in Patients Undergoing Remote Ischemic Conditioning Before Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction: a Follow-up Study

Condition:   ST-elevation Myocardial Infarction (STEMI)
Intervention:   Procedure: Remote ischemic perconditioning
Sponsors:   University of Aarhus;   Aarhus University Hospital;   Oxford University Hospitals NHS Trust;   The Hospital for Sick Children
Active, not recruiting - verified August 2013

CYCLosporinE A in Reperfused Acute Myocardial Infarction

Condition:   Acute Myocardial Infarction
Intervention:   Drug: Cyclosporine A
Sponsors:   Mario Negri Institute for Pharmacological Research;   Heart Care Foundation
Completed - verified October 2013

Prevention Trial to Achieve Cardiovascular Targets

Conditions:   Coronary Artery Disease;   Peripheral Arterial Disease;   Hyperlipidemia;   Hypertension;   Diabetes;   Prediabetes;   Obesity
Interventions:   Behavioral: Prevention Consult;   Behavioral: Consult & Behavioral Intervention
Sponsors:   New York University School of Medicine;   The Rainer Arnhold Foundation
Recruiting - verified April 2015

Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)

Conditions:   Major Depressive Disorder;   Depression;   Depressive Symptoms;   Cardiovascular Disease (CVD);   Coronary Artery Disease (CAD);   Heart Disease
Interventions:   Drug: Pentoxifylline;   Other: Placebo;   Behavioral: Standard Treatment
Sponsors:   Indiana University;   National Institute of Mental Health (NIMH)
Completed - verified April 2015

The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes

Conditions:   Coronary Artery Disease;   Diabetes Mellitus, Type 2
Interventions:   Drug: Liraglutide;   Drug: Placebo
Sponsor:   Haugaard, Steen Bendix, M.D., DMSc
Active, not recruiting - verified April 2015

Bifurcation Stenting Using 2 Link Stent Nobori Versus 3 Link Stent Xience

Condition:   Coronary Stenosis
Intervention:   Device: Bifurcation stenting
Sponsor:   Kurashiki Central Hospital
Active, not recruiting - verified April 2015

The Supplementary Role of Non-invasive Imaging to Routine Clinical Practice in Suspected Non-ST-elevation Myocardial Infarction

Conditions:   Chest Pain;   Myocardial Infarction;   Acute Coronary Syndrome;   Coronary Artery Disease;   Myocardial Ischemia
Interventions:   Other: Cardiovascular Magnetic Resonance Imaging;   Other: Computed Tomography Angiography
Sponsors:   Maastricht University Medical Center;   Dutch Heart Foundation
Recruiting - verified April 2015

A Study of 123I-CMICE-013 Radiopharmaceutical in Healthy Volunteers

Condition:   Coronary Artery Disease
Intervention:   Drug: 123I-CMICE-013
Sponsors:   Ottawa Heart Institute Research Corporation;   Canadian Institutes of Health Research  (CIHR)
Active, not recruiting - verified April 2015

Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention

Conditions:   Myocardial Infarction;   Acute Coronary Syndromes;   Unstable Angina
Interventions:   Drug: Short Tirofiban;   Drug: Eptifibatide;   Drug: Long Tirofiban
Sponsors:   Medicure;   SCRI Development Innovations, LLC
Recruiting - verified April 2015

Cyclosporine and Prognosis in Acute Myocardial Infarction (MI) Patients

Condition:   ST Elevation Acute Myocardial Infarction
Interventions:   Drug: Injection of Cyclosporin;   Drug: Placebo;   Procedure: Echocardiography
Sponsor:   Hospices Civils de Lyon
Active, not recruiting - verified April 2015

Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in Side Branches of de Novo Bifurcation Lesions (DEBSIDE)

Condition:   Coronary Disease
Intervention:   Device: Danubio paclitaxel-eluting balloon
Sponsors:   MINVASYS;   European Cardiovascular Research  Center
Completed - verified November 2013

Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in In-Stent Restenosis Lesions (DEBREST)

Condition:   In-stent Coronary Artery Restenosis
Intervention:   Device: Danubio paclitaxel-eluting balloon
Sponsors:   MINVASYS;   European Cardiovascular Research  Center
Completed - verified November 2013

Long-term Results Following Endoscopic Vein Harvesting in Coronary Artery Bypass Surgery

Condition:   Angina Pectoris
Intervention:   Procedure: Surgery
Sponsors:   Aalborg Universitetshospital  ;   Aalborg University
Completed - verified November 2011

A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease

Condition:   Crohn's Disease
Interventions:   Drug: CP-690,550;   Drug: CP-690,550
Sponsor:   Pfizer
Recruiting - verified April 2015

Randomized, Open Label Trial of 6 Months Versus 12 Months DAPT After Drug-Eluting Stent in STEMI

Conditions:   Myocardial Infarction;   Cardiovascular Disease
Interventions:   Other: 6 months DAPT;   Other: 12 months DAPT
Sponsors:   Maasstad Hospital;   Medtronic
Recruiting - verified April 2015

Vest Prevention of Early Sudden Death Trial and VEST Registry

Conditions:   Myocardial Infarction;   Ventricular Dysfunction;   Sudden Death;   Ventricular Tachycardia;   Ventricular Fibrillation
Intervention:   Device: wearable defibrillator
Sponsors:   University of California, San Francisco;   Zoll Medical Corporation
Recruiting - verified April 2015

The "Virtual" Multicenter Spontaneous Coronary Artery Dissection (SCAD) Registry

Conditions:   Spontaneous Coronary Artery Dissection;   SCAD
Intervention:  
Sponsor:   Mayo Clinic
Recruiting - verified April 2015

Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD.

Conditions:   Myocardial Infarction;   Multivessel Coronary Artery Disease
Interventions:   Procedure: FFR-guided revascularisation strategy;   Procedure: randomised to guidelines group
Sponsors:   Maasstad Hospital;   Abbott Vascular;   St. Jude Medical
Recruiting - verified April 2015

Multi-modality Imaging of Ischemia With 18F-FDG PET and CTA

Condition:   Myocardial Ischemia
Intervention:   Radiation: PET MPI imaging with 18F-Fluorodeoxyglucose
Sponsor:   Ottawa Heart Institute Research Corporation
Active, not recruiting - verified April 2015

Optimization of SPECT Imaging

Condition:   Coronary Artery Disease
Intervention:   Radiation: SPECT/CT processed with Evolution for CardiacTM software
Sponsor:   Ottawa Heart Institute Research Corporation
Terminated - verified April 2015

Fondaparinux EU-RMP (Adherence)

Conditions:   ST-elevation Myocardial Infarction;   Unstable Angina;   Non ST Segment Elevation Myocardial Infarction;   Acute Coronary Syndrome
Intervention:   Drug: fondaparinux
Sponsor:   GlaxoSmithKline
Completed - verified April 2015

Stress Echocardiography and Heart Computed Tomography (CT) Scan in Emergency Department Patients With Chest Pain

Conditions:   Chest Pain;   Angina;   Angina Pectoris;   Coronary Artery Disease
Interventions:   Procedure: Stress Echocardiography;   Procedure: Coronary CT Angiography
Sponsors:   Montefiore Medical Center;   American Heart Association
Recruiting - verified April 2015

Clearance Of Mucus In Stents

Conditions:   Lung Neoplasms;   Respiratory Failure;   Pneumonia;   Acute Coronary Syndromes;   Unstable Angina;   Myocardial Infarction;   Cardiac Arrhythmia;   Thromboembolic Disease
Interventions:   Other: Normal Saline;   Other: Sodium Bicarbonate
Sponsor:   M.D. Anderson Cancer Center
Recruiting - verified April 2015

Drug Drug Interactions of Aspirin and P2Y12-inhibitors

Conditions:   VA Drug Interactions [VA Drug Interaction];   Myocardial Infarction
Interventions:   Drug: Morphine;   Drug: Placebo
Sponsor:   Medical University of Vienna
Completed - verified April 2015

Safety and Efficacy Study of Intramyocardial Stem Cell Therapy in Patients With Dilated Cardiomyopathy

Conditions:   Dilated Cardiomyopathy;   Chronic Heart Failure
Interventions:   Procedure: Intramyocardial injection;   Procedure: Intracoronary injection;   Procedure: Intramyocardial injection
Sponsors:   University Medical Centre Ljubljana;   The Methodist Hospital System;   Stanford University
Completed - verified April 2015

Resolute Zotarolimus-Eluting Stent Versus the Taxus Liberte Paclitaxel-Eluting Stent for Percutaneous Coronary Intervention in China

Conditions:   Ischemic Heart Disease;   Stenotic Coronary Lesion;   Cardiovascular Diseases;   Arteriosclerosis;   Coronary Artery Disease
Interventions:   Device: Taxus Liberte Paclitaxel-Eluting Coronary Stent System;   Device: Resolute Zotarolimus-Eluting Coronary Stent System
Sponsor:   Medtronic Vascular
Active, not recruiting - verified April 2015

Survival After First Myocardial Infarction in Patients With and Without Chronic Obstructive Pulmonary Disease

Conditions:   Myocardial Infarction;   Chronic Obstructive Pulmonary Disease
Intervention:  
Sponsors:   London School of Hygiene and Tropical Medicine;   British Medical Research Council;   University College, London
Completed - verified April 2015

Pharmacodynamic Study on Efficacy of Clopidogrel With St. John's Wort

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Placebo;   Drug: St. Johns Wort
Sponsors:   Lancaster General Hospital;   H. G. Barsumian Memorial Fund;   Louise von Hess Medical Research Institute
Terminated - verified April 2015

Safety and Efficacy Study of the Nile PAX Drug-Eluting Coronary Bifurcation Stent

Condition:   Coronary Disease
Intervention:   Device: Nile PAX® paclitaxel-eluting coronary stent
Sponsor:   MINVASYS
Completed - verified November 2013

Telemonitoring During Phase 2-3 Cardiac Rehabilitation

Condition:   Ischemic Heart Disease
Intervention:   Device: physical activity monitors
Sponsor:   Jessa Hospital
Completed - verified April 2015

Evaluation of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a Real-World Patient Population in China

Conditions:   Ischemic Heart Disease;   Stenotic Coronary Lesion;   Cardiovascular Diseases;   Arteriosclerosis;   Coronary Artery Disease
Intervention:  
Sponsor:   Medtronic Vascular
Active, not recruiting - verified April 2015

Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention

Conditions:   Myocardial Infarction;   Acute Coronary Syndromes;   Unstable Angina;   Percutaneous Coronary Intervention
Interventions:   Drug: Tirofiban (Aggrastat);   Drug: Placebo
Sponsors:   Medicure;   SCRI Development Innovations, LLC
Suspended - verified April 2015

Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis

Conditions:   Hypertrophic Cardiomyopathy;   Acute Coronary Syndrome
Intervention:   Radiation: 99mTc-NC100692
Sponsor:   Ottawa Heart Institute Research Corporation
Active, not recruiting - verified April 2015

Nitroglycerin in Non-small Cell Lung Cancer

Condition:   Non Small Cell Lung Cancer (NSCLC)
Intervention:   Drug: Nitroglycerin patch
Sponsors:   Maastricht Radiation Oncology;   Reliable Cancer Therapies;   Anticancer Fund, Belgium
Recruiting - verified April 2015

Vitamin D Supplementation in CAD and Postchallenge Hyperglycemia

Conditions:   Coronary Artery Disease;   Postprandial Hyperglycemia;   Vitamin D Deficiency
Intervention:   Drug: vitamin D
Sponsor:   Medical University of Graz
Terminated - verified April 2015

Humanalbumin, Hydroxyethylstarch and Ringer Lactate During Cardiac Surgery

Conditions:   Valvular Heart Disease;   Coronary Artery Disease
Interventions:   Drug: volume replacement;   Drug: Humanalbumin 5%;   Drug: volume replacement
Sponsor:   Medical University of Vienna
Completed - verified April 2015

RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia

Conditions:   Ischemic Heart Disease;   Stenotic Coronary Lesion;   Cardiovascular Diseases;   Arteriosclerosis;   Coronary Artery Disease
Intervention:   Device: Drug eluting stent treatment
Sponsor:   Medtronic Vascular
Active, not recruiting - verified April 2015

The Massachusetts General Hospital Optical Coherence Tomography Registry

Condition:   Coronary Artery Disease
Intervention:  
Sponsors:   Ik-Kyung Jang, MD, PhD;   Medtronic;   Boston Scientific Corporation;   Massachusetts General Hospital
Active, not recruiting - verified April 2015

Study Comparing CT Scan and Stress Test in Patients With Known Coronary Artery Disease Hospitalized for Chest Pain

Conditions:   Coronary Artery Disease;   Angina Pectoris;   Unstable Angina;   Acute Coronary Syndrome
Interventions:   Procedure: Coronary CT angiography;   Procedure: Myocardial perfusion imaging
Sponsors:   Montefiore Medical Center;   Albert Einstein College of Medicine of Yeshiva University
Terminated - verified April 2015

Aspirin Resistance and Percutaneous Coronary Intervention (PCI)

Condition:   Stable Angina
Interventions:   Drug: Intravenous Glycoprotein inhibitor + ASA, Clopidogrel;   Drug: Antiplatelet Therapy (ASA, Clopidogrel)
Sponsor:   Mount Sinai School of Medicine
Completed - verified April 2015

Time To Complications Occurs in Diabetes

Conditions:   Retinopathy;   Nephropathy;   Diabetic Neuropathy;   Vascular Disease;   Ischemic Heart Disease
Intervention:  
Sponsor:   Karolinska Institutet
Enrolling by invitation - verified May 2012

ABSORB Clinical Investigation, Cohort B

Conditions:   Coronary Disease;   Coronary Artery Disease;   Coronary Restenosis
Intervention:   Device: Bioabsorbable Everolimus Eluting Coronary Stent
Sponsor:   Abbott Vascular
Active, not recruiting - verified April 2015

The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart Failure

Condition:   Heart Failure
Interventions:   Drug: LOVAZA (Omega-3);   Drug: Placebo
Sponsors:   Columbia University;   GlaxoSmithKline
Terminated - verified April 2015

Etanercept in Kawasaki Disease

Conditions:   Mucocutaneous Lymph Node Syndrome;   Kawasaki Disease
Interventions:   Drug: Etanercept;   Drug: Placebo
Sponsors:   Michael Portman;   Amgen
Recruiting - verified April 2015

Comparing the Effectiveness of Repairing Versus Replacing the Heart's Mitral Valve in People With Severe Chronic Ischemic Mitral Regurgitation

Conditions:   Mitral Valve Insufficiency;   Coronary Artery Disease
Interventions:   Procedure: Mitral Valve Repair with Annuloplasty;   Procedure: Mitral Valve Replacement
Sponsors:   Mount Sinai School of Medicine;   National Heart, Lung, and Blood Institute (NHLBI);   Canadian Institutes of Health Research  (CIHR);   National Institute of Neurological Disorders and Stroke (NINDS)
Completed - verified April 2015

Comparing the Effectiveness of a Mitral Valve Repair Procedure in Combination With Coronary Artery Bypass Grafting (CABG) Versus CABG Alone in People With Moderate Ischemic Mitral Regurgitation

Conditions:   Mitral Valve Insufficiency;   Coronary Artery Disease
Interventions:   Procedure: Mitral Valve Repair;   Procedure: CABG
Sponsors:   Mount Sinai School of Medicine;   National Heart, Lung, and Blood Institute (NHLBI);   Canadian Institutes of Health Research  (CIHR);   National Institute of Neurological Disorders and Stroke (NINDS)
Active, not recruiting - verified April 2015

Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia

Condition:   Metabolic Syndrome
Interventions:   Drug: Pravastatin, Fenofibrate, Metformin, Orlistat, irbesartan;   Other: As selected by community physician
Sponsor:   North Shore Long Island Jewish Health System
Terminated - verified November 2011

Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial

Condition:   Acute Coronary Syndrome
Interventions:   Drug: varenicline;   Other: placebo
Sponsors:   Mark Eisenberg;   St. Michael's Hospital, Toronto;   Sunnybrook Health Sciences Centre;   Queen Elizabeth II Health Sciences Centre
Active, not recruiting - verified April 2015

Study Comparing CT Scan and Stress Test in Diagnosing Coronary Artery Disease in Patients Hospitalized for Chest Pain

Conditions:   Coronary Artery Disease;   Angina Pectoris;   Unstable Angina;   Acute Coronary Syndrome
Interventions:   Procedure: Coronary Computed Tomography Angiography;   Procedure: Stress Nuclear Myocardial Perfusion Imaging
Sponsors:   Montefiore Medical Center;   American Heart Association;   Albert Einstein College of Medicine of Yeshiva University
Completed - verified April 2015

Prospective Observational Epidemiologic Study of Maraviroc's Safety

Condition:   Human Immunodeficiency Virus
Interventions:   Drug: Maraviroc along with an optimized background antiretroviral drug regimen;   Drug: Optimized background antiretroviral drug regimen without maraviroc
Sponsors:   ViiV Healthcare;   Pfizer
Active, not recruiting - verified April 2015

Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)

Conditions:   Atherosclerosis;   Hypercholesterolemia;   Coronary Heart Disease
Interventions:   Drug: Ezetimibe;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified April 2015

Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)

Conditions:   Hypercholesterolemia;   Atherosclerosis
Interventions:   Drug: Ezetimibe + Atorvastatin;   Drug: Atorvastatin
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified April 2015

Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)

Conditions:   Hypercholesterolaemia;   Atherosclerosis
Interventions:   Drug: Ezetimibe + Simvastatin;   Drug: Simvastatin
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified April 2015

Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)

Conditions:   Hypercholesterolemia;   Atherosclerosis
Interventions:   Drug: Ezetimibe;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified April 2015

Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)

Conditions:   Hypercholesterolemia;   Atherosclerosis
Interventions:   Drug: Ezetimibe;   Drug: Placebo
Sponsors:   Merck Sharp & Dohme Corp.;   Merck Frosst Canada Ltd.
Terminated - verified April 2015

Vascular Events In Noncardiac Surgery Patients Cohort Evaluation Study (VISION)

Conditions:   Vascular Death;   Myocardial Infarction;   Cardiac Arrest;   Stroke
Intervention:  
Sponsors:   Hamilton Health Sciences Corporation;   Roche Diagnostic Ltd.;   Heart and Stroke Foundation of Ontario;   Population Health Research Institute;   Ontario Ministry of Research and Innovation;   McMaster University;   CLARITY Group
Completed - verified April 2015

The Effect of Training on Endothelial Function, Progression of Disease,Inflammation, Heart Rate Variability and Mental Health After Percutaneous Coronary Intervention

Condition:   Coronary Artery Disease
Intervention:   Behavioral: exercise training
Sponsor:   Helse Stavanger HF
Completed - verified February 2009

Heart Outcomes Prevention Evaluation-3

Conditions:   Cardiovascular Disease;   Stroke
Interventions:   Drug: Candesartan/HCT;   Drug: Rosuvastatin
Sponsor:   Population Health Research Institute
Active, not recruiting - verified April 2015

The Diagnostic Benefits of the HyperQTM System in ECG Stress Testing

Condition:   Myocardial Ischemia
Intervention:   Device: Excercise stress test with high frequency ECG recording (HyperQ™ System)
Sponsors:   Assuta Hospital Systems;   BSP Biological Signal Processing Ltd.
Recruiting - verified October 2006

Development of Computer-aided Detection and Diagnosis From Imaging Techniques

Condition:   Cancer
Intervention:  
Sponsor:   National Institutes of Health Clinical Center (CC)
Recruiting - verified April 2014

Isoflavones and the Coronary Circulation in Men and Women With Coronary Artery Disease

Condition:   Coronary Artery Disease
Intervention:   Drug: genistein (Supro)
Sponsor:   Imperial College London
Completed - verified February 2006

Evaluation of a Web-based Intervention to Promote Physical Activity in Patients With Heart Disease.

Condition:   Coronary Artery Disease (CAD)
Intervention:   Behavioral: CardioFit
Sponsors:   Ottawa Heart Institute Research Corporation;   Heart and Stroke Foundation of Ontario
Completed - verified March 2009

Endoscopic Vessel Harvesting During Coronary Bypass Surgery

Condition:   Coronary Arteriosclerosis
Intervention:   Procedure: vein harvest
Sponsor:   Aalborg Universitetshospital  
Completed - verified April 2015

Exercise-training Before Coronary Artery Bypass Graft (CABG)

Conditions:   Angina;   Coronary Artery Disease
Intervention:   Behavioral: Exercise training
Sponsor:   Norwegian University of Science and Technology
Recruiting - verified April 2015

Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life-threatening Heart Rhythms (ABCD Study)

Conditions:   Ischemic Cardiomyopathy;   LV Dysfunction
Intervention:   Device: T-Wave Alternans test
Sponsors:   St. Jude Medical;   Cambridge Heart Inc.;   MetroHealth Medical Center
Completed - verified April 2015

Collaborative Cardiac Care Project

Conditions:   Myocardial Ischemia;   Angina Pectoris;   Coronary Disease
Interventions:   Procedure: Collaborative care model;   Procedure: Group interventions;   Procedure: Facilitated consultation
Sponsor:   Department of Veterans Affairs
Completed - verified October 2007

From Research to Practice - Lipid Management for Low HDL-Cholesterol

Conditions:   Physicians' Practice Patterns;   Coronary Heart Disease
Intervention:   Behavioral: education and reminder
Sponsor:   Department of Veterans Affairs
Completed - verified February 2007

Implementation of Ischemic Heart Disease Clinical Practice Guidelines

Condition:   Ischemic Heart Disease
Intervention:  
Sponsor:   Department of Veterans Affairs
Completed - verified January 2005

Get CardioSmart

You're Invited